Association between serum vitamin C and chronic kidney disease among adults in NHANES, 2017-2018

References

• Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Kidney Int. 2002;62:1402–1407. doi: 10.1111/j.1523-1755.2002.kid571.x
   PubMed Web of Science ®Google Scholar
• Muntner P, He J, Hamm L. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745–753. doi: 10.1681/ASN.V133745
   PubMed Web of Science ®Google Scholar
• Leoncini G, Viazzi F, Parodi D, et al. Mild renal dysfunction and cardiovascular risk in hypertensive patients. J Am Soc Nephrol. 2004;15(1_suppl):S88–S90. doi: 10.1097/01.ASN.0000093245.78097.CD
   PubMed Web of Science ®Google Scholar
• Oh SW, Baek SH, Kim YC, et al. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population. Nephrol Dial Transpl. 2012;27(6):2284–2290. doi: 10.1093/ndt/gfr622
   PubMed Web of Science ®Google Scholar
• Soveri I, Berg UB, Björk J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411–424. doi: 10.1053/j.ajkd.2014.04.010
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A, Disease K, et al. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825–830. doi: 10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–2100. doi: 10.1111/j.1523-1755.2005.00365.x
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Balk E. National kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–147. doi: 10.7326/0003-4819-139-2-200307150-00013
   PubMed Web of Science ®Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11:e0158765. doi: 10.1371/journal.pone.0158765
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Rayego-Mateos S, Lamas S. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269–288. doi: 10.1038/s41581-019-0248-y
   PubMed Web of Science ®Google Scholar
• Murton M, Goff-Leggett D, Bobrowska A. Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review. Adv Ther. 2021;38(1):180–200. doi: 10.1007/s12325-020-01568-8
   PubMed Web of Science ®Google Scholar
• Tyml K. Vitamin C and microvascular dysfunction in systemic inflammation. Antioxidants. 2017;6(3):49. doi: 10.3390/antiox6030049
   Web of Science ®Google Scholar
• Yu RJ, Van Scott EJ. Alpha-hydroxyacids and carboxylic acids. J Cosmet Dermatol. 2004;3(2):76–87. doi: 10.1111/j.1473-2130.2004.00059.x
   PubMedGoogle Scholar
• Korkmaz A, Kolankaya D. The protective effects of ascorbic acid against renal ischemia-reperfusion injury in male rats.Ren. Fail. 2009;31:36–43. doi: 10.1080/08860220802546271
   PubMed Web of Science ®Google Scholar
• Moreira MA, Nascimento MA, Bozzo TA. Ascorbic acid reduces gentamicin-induced nephrotoxicity in rats through the control of reactive oxygen species. Clin Nutr. 2014;33:296–301. doi: 10.1016/j.clnu.2013.05.005
   PubMed Web of Science ®Google Scholar
• Sanadi RM, Deshmukh RS. The effect of vitamin C on melanin pigmentation - a systematic review. J Oral Maxillofac Pathol: JOMFP. 2020;24(2):374–382. doi: 10.4103/jomfp.JOMFP_207_20
   PubMedGoogle Scholar
• Blaszczak W, Barczak W, Masternak J. Vitamin C as a modulator of the response to cancer therapy. Molecules. 2019;24(3):453. doi: 10.3390/molecules24030453
   PubMed Web of Science ®Google Scholar
• Koyner JL, Sher Ali R, Murray PT. Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron Exp Nephrol. 2008;109(4):e109–17. doi: 10.1159/000142935
   PubMedGoogle Scholar
• Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease. Nutrients. 2017;9(7):718. doi: 10.3390/nu9070718
   PubMed Web of Science ®Google Scholar
• Rehman K, Akash MS, Azhar S. A biochemical and histopathologic study showing protection and treatment of gentamicin-induced nephrotoxicity in rabbits using vitamin C. Afr J Tradit Complement Altern Med. 2012;9(3):360–365. doi: 10.4314/ajtcam.v9i3.9
   PubMedGoogle Scholar
• Hongsawong N, Chawprang N, Kittisakmontri K. Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease. Pediatr Nephrol. 2021;36(2):397–408. doi: 10.1007/s00467-020-04662-9
   PubMed Web of Science ®Google Scholar
• US CDC National Center for Health Statistics NHANES Comprehensive Data List. [cited 6 Jun 2022]; Available from: https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx
   Google Scholar
• US CDC. National center for health Statistics National health and Nutrition Examination 364 Survey NCHS Research ethics review board (erb) approval. 365. [cited 19 Sep 2022]; Available from: https://www.cdc.gov/nchs/nhanes/irba98.htm.
   Google Scholar
• Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin c-based equations to estimate GFR without race. N Engl J Med. 2021 Nov 4;385(19):1737–1749. doi: 10.1056/NEJMoa2102953
   PubMed Web of Science ®Google Scholar
• Eckardt KU, Coresh J, Devuyst O. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–169. doi: 10.1016/S0140-6736(13)60439-0
   PubMed Web of Science ®Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765
   PubMed Web of Science ®Google Scholar
• Duan J, Wang C, Liu D, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep. 2019;9(1):10408. doi: 10.1038/s41598-019-46857-7
   PubMed Web of Science ®Google Scholar
• Liu M, Liu S-W, Wang L-J, et al. Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. Diabetes Metab. 2018;45(3):286–293. doi: 10.1016/j.diabet.2018.08.008
   PubMed Web of Science ®Google Scholar
• Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19–28. doi: 10.1053/j.ackd.2015.08.004
   PubMed Web of Science ®Google Scholar
• Mallappallil M, Friedman EA, Delano BG, et al. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond). 2014;11:525–535. doi: 10.2217/cpr.14.46
   PubMedGoogle Scholar
• Komenda P, Ferguson TW, Macdonald K. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789–797. doi: 10.1053/j.ajkd.2013.12.012
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22(6):463–493. doi: 10.1111/odi.12446
   PubMed Web of Science ®Google Scholar
• Doseděl M, Jirkovský E, Macáková K. Vitamin C-Sources, physiological role, kinetics, deficiency, use, toxicity, and determination. Nutrients. 2021;13(2):615. doi: 10.3390/nu13020615
   PubMed Web of Science ®Google Scholar
• Kadi IE, Dahdouh F. Vitamin C pretreatment protects from nickel-induced acute nephrotoxicity in mice. Arh Hig Rada Toksikol. 2016;67(3):210–215. doi: 10.1515/aiht-2016-67-2753
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998;53(6):1748–1754. doi: 10.1046/j.1523-1755.1998.00947.x
   PubMed Web of Science ®Google Scholar
• Tepel M, Echelmeyer M, Orie NN, et al. Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney Int. 2000;58(2):867–872. doi: 10.1046/j.1523-1755.2000.00236.x
   PubMed Web of Science ®Google Scholar
• Kelly D, Rothwell PM. Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry. 2020;91(1):88–97. doi: 10.1136/jnnp-2019-320526
   PubMed Web of Science ®Google Scholar
• Descamps-Latscha B, Drüeke T, Witko-Sarsat V. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial. 2001;14(3):193–199. doi: 10.1046/j.1525-139X.2001.00052.x
   PubMed Web of Science ®Google Scholar
• Farhadnejad H, Asghari G, Mirmiran P. Micronutrient Intakes and incidence of chronic kidney disease in adults: Tehran lipid and glucose study. Nutrients. 2016 Apr 20;8(4):217. doi: 10.3390/nu8040217
   PubMed Web of Science ®Google Scholar
• Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J. 2011;75:2739–2748. doi: 10.1253/circj.CJ-11-1184
   PubMed Web of Science ®Google Scholar
• De Oliveira Otto MC, Alonso A, Lee DH, et al. Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis. J Nutr. 2011;141:1508–1515. doi: 10.3945/jn.111.138115
   PubMed Web of Science ®Google Scholar
• Tian N, Thrasher KD, Gundy PD, et al. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension. 2005;45:934–939. doi: 10.1161/01.HYP.0000160404.08866.5a
   PubMed Web of Science ®Google Scholar
• Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319–329. doi: 10.1681/ASN.V112319
   PubMed Web of Science ®Google Scholar
• Dumanski SM, Ramesh S, James MT. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis. Syst Rev. 2017;6(1):134. doi: 10.1186/s13643-017-0519-2
   PubMedGoogle Scholar
• Ahmed SB, Ramesh S. Sex hormones in women with kidney disease. Nephrol Dial Transplant. 2016;31(11):1787–1795. doi: 10.1093/ndt/gfw084
   PubMed Web of Science ®Google Scholar
• Brar A, Markell M. Impact of gender and gender disparities in patients with kidney disease. Curr Opin Nephrol Hypertens. 2019;28:178–182. doi: 10.1097/MNH.0000000000000482
   PubMed Web of Science ®Google Scholar
• Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–582. doi: 10.1016/S0140-6736(20)31561-0
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Hecking M, Chesnaye NC, et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–164. doi: 10.1038/nrneph.2017.181
   PubMed Web of Science ®Google Scholar
• Inker LA, Coresh J, Levey AS. Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol. 2011;22:2322–2331. doi: 10.1681/ASN.2010111181
   PubMed Web of Science ®Google Scholar
• Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1):47–55. doi: 10.1016/S0735-1097(02)02663-3
   PubMed Web of Science ®Google Scholar
• So WY, Kong APS, RCW M, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006;29:2046–2052. doi: 10.2337/dc06-0248
   PubMed Web of Science ®Google Scholar